Treatment of White Vaginal Discharge with Foul Odor in Diabetic Patients

Diagnostic Approach

The Centers for Disease Control and Prevention recommends measuring vaginal pH using narrow-range pH paper, where pH >4.5 suggests bacterial vaginosis or trichomoniasis, while pH ≤4.5 indicates candidiasis 3, 4, 1
A microscopic examination with two preparations, including a saline wet mount to identify clue cells or motile trichomonads, and a 10% KOH preparation to identify yeast/pseudohyphae, is essential for diagnosis 3, 4, 1, 2
The whiff test, which involves applying KOH to the discharge, can help diagnose bacterial vaginosis if a fishy odor is present 3, 4, 2

The American College of Obstetricians and Gynecologists notes that bacterial vaginosis is characterized by a homogeneous white, non-inflammatory discharge with a characteristic fishy odor 1, 2
Diagnosis requires 3 of 4 Amsel criteria: characteristic discharge, clue cells on microscopy, pH >4.5, and positive whiff test 2
Treatment options include metronidazole 500 mg orally twice daily for 7 days, metronidazole gel 0.75% intravaginally once daily for 5 days, or clindamycin cream 2% intravaginally at bedtime for 7 days 2, 1

The Infectious Diseases Society of America recommends diagnosing vulvovaginal candidiasis based on clinical presentation, including white, thick discharge, pruritus, vulvar irritation, and burning, and confirming with yeast/pseudohyphae on KOH preparation or positive culture 5, 2
Treatment options include fluconazole 150 mg orally as a single dose, or intravaginal azoles for 1-7 days 5, 2
For complicated or recurrent candidiasis, initial induction therapy with 7-14 days of topical azole or fluconazole 150 mg every 72 hours for 3 doses, followed by maintenance therapy with fluconazole 150 mg orally once weekly for 6 months, is recommended 5, 1

The American Diabetes Association emphasizes the importance of glycemic control in managing vulvovaginal candidiasis, as poor glucose control promotes yeast attachment, growth, and recurrence 1, 2
Diabetic women may require longer treatment courses and have higher treatment failure rates compared to non-diabetic women 5, 1

The Centers for Disease Control and Prevention recommends returning for evaluation only if symptoms persist or recur within 2 months 1
For recurrent infections, reassessing glycemic control and considering long-term suppressive therapy is recommended 5, 1